10x Genomics, Inc. (FRA:1KJ)

Germany flag Germany · Delayed Price · Currency is EUR
14.60
-0.63 (-4.14%)
At close: Dec 4, 2025
-3.88%
Market Cap 1.97B
Revenue (ttm) 547.02M
Net Income (ttm) -65.05M
Shares Out n/a
EPS (ttm) -0.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,045
Average Volume 218
Open 15.15
Previous Close 15.23
Day's Range 14.60 - 15.15
52-Week Range 6.12 - 17.44
Beta n/a
RSI 53.32
Earnings Date Feb 13, 2026

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as ... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2012
Employees 1,306
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 1KJ
Full Company Profile

Financial Performance

In 2024, 10x Genomics's revenue was $610.79 million, a decrease of -1.28% compared to the previous year's $618.73 million. Losses were -$182.63 million, -28.41% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.